Tobramycin Inhalation Solution 300mg | Tobamist - Cipla

Advanced Targeted Respiratory Antibiotic Therapy

When managing severe, chronic respiratory infections—particularly those caused by Pseudomonas aeruginosa in cystic fibrosis or bronchiectasis patients—healthcare providers require a highly targeted and aggressive intervention. The Tobramycin Inhalation Solution IP 300 mg/5ml (commercially recognized as Tobamist Respules) provides a potent aminoglycoside antibiotic therapy designed strictly for inhalation. Manufactured by Cipla, a globally respected pioneer in respiratory care, these sterile respules ensure the steady clinical performance necessary for intensive pulmonary protocols.

Why Choose Tobamist for Pulmonary Infection Management?

Tackling deep-seated lung infections requires an antibiotic that can reach the site of infection directly. Instead of relying solely on intravenous or oral antibiotics that must travel systemically, clinical specialists benefit from Tobamist’s direct-to-lung formulation. Administered via a nebulizer, this inhalation solution delivers a highly concentrated dose of Tobramycin straight to the airways, maximizing bacterial eradication while minimizing systemic side effects. Cipla ensures the absolute, stringent quality control demanded in critical respiratory care.

Key Product Specifications & Clinical Benefits

Potent Active Ingredient: Each 5 ml respule contains premium-grade Tobramycin IP equivalent to 300 mg, delivering a highly concentrated antibiotic dose for effective pulmonary care.

Ready-to-Use Format: Supplied as a 5 x 5 ml pack of single-use respules (ampoules), ensuring precise dosing and maximum sterility for every nebulizer session.

Targeted Local Delivery: Formulated strictly for inhalation only, guaranteeing optimal local bioavailability in the lungs for a rapid therapeutic response.

Seamless Compatibility: Designed to be easily administered using standard clinical and home-use respirators or nebulizers.

Essential Storage & Usage Guidelines

Maintaining the integrity of this sensitive respiratory medication is vital for its clinical efficacy.

Refrigeration Required: The pouches should generally be stored under refrigeration at 2°C to 8°C (36°F to 46°F).

Room Temperature Allowance: Upon removal from the refrigerator, or if refrigeration is unavailable, the pouches may be stored at room temperature (up to 25°C) for up to 28 days. Protect strictly from intense light. Caution: This product should be used with a respirator or nebulizer only. It is not to be injected or administered orally.

Important Notice: Tobamist is a Schedule H Prescription Drug. Caution: Not to be sold by retail without the prescription of a Registered Medical Practitioner. Keep all medicines safely out of the reach of children.